The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-((3-(3-(N-(4-Aminocyclohexyl)sulfamoyl)-4-methoxyphenyl)-6-chloro-2-methylimidazo[1,2-b]pyridazin-8-yl)amino)ethyl)-acetamide ID: ALA3986552
PubChem CID: 123131774
Max Phase: Preclinical
Molecular Formula: C24H32ClN7O4S
Molecular Weight: 550.09
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(-c2c(C)nc3c(NCCNC(C)=O)cc(Cl)nn23)cc1S(=O)(=O)NC1CCC(N)CC1
Standard InChI: InChI=1S/C24H32ClN7O4S/c1-14-23(32-24(29-14)19(13-22(25)30-32)28-11-10-27-15(2)33)16-4-9-20(36-3)21(12-16)37(34,35)31-18-7-5-17(26)6-8-18/h4,9,12-13,17-18,28,31H,5-8,10-11,26H2,1-3H3,(H,27,33)
Standard InChI Key: HORACVGDHNAIMC-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 40 0 0 0 0 0 0 0 0999 V2000
8.0701 -13.4529 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8596 -14.2453 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.6511 -14.0314 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8512 -12.5387 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.5520 -12.1271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5479 -11.3099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2528 -10.8983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2487 -10.0812 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5396 -9.6756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8347 -10.0872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1215 -9.6858 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1174 -8.8686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4042 -8.4631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8223 -8.4529 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2652 -12.5327 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9702 -12.1210 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.9619 -11.2998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7407 -11.0414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2234 -11.7039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0405 -11.6956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7458 -12.3678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0042 -13.1425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4625 -13.7545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7209 -14.5291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5210 -14.6918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7794 -15.4664 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2377 -16.0784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0627 -14.0798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1668 -15.0060 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.8084 -13.3052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9836 -15.0329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3632 -15.7544 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1763 -15.7831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6117 -15.0911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2279 -14.3686 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4086 -14.3380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4283 -15.1211 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
12 14 2 0
5 15 2 0
15 16 1 0
16 17 1 0
7 17 1 0
17 18 2 0
18 19 1 0
19 20 1 0
19 21 2 0
16 21 1 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 1 0
25 28 1 0
28 2 1 0
2 29 1 0
28 30 2 0
22 30 1 0
29 31 1 0
31 32 1 0
31 36 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
34 37 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 550.09Molecular Weight (Monoisotopic): 549.1925AlogP: 2.46#Rotatable Bonds: 9Polar Surface Area: 152.74Molecular Species: BASEHBA: 9HBD: 4#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 2CX Acidic pKa: 9.39CX Basic pKa: 10.23CX LogP: -0.07CX LogD: -1.77Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.30Np Likeness Score: -1.44
References 1. Mejdrová I, Chalupská D, Plačková P, Müller C, Šála M, Klíma M, Baumlová A, Hřebabecký H, Procházková E, Dejmek M, Strunin D, Weber J, Lee G, Matoušová M, Mertlíková-Kaiserová H, Ziebuhr J, Birkus G, Boura E, Nencka R.. (2017) Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIβ (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical Biology., 60 (1): [PMID:28004945 ] [10.1021/acs.jmedchem.6b01465 ]